Best Practice & Research Clinical Endocrinology & Metabolism · Sep 10, 2021
Hormone therapy and cardiovascular disease: Benefits and harms
By Maas AHEM
Menopause transition marks an important phase in life when cardiovascular risk in women gradually takes an adverse turn. Although menopausal hormone therapy has gained a negative appreciation over the last decades, its value in the treatment of disabling vasomotor symptoms is still undisputed. Cardiovascular risk assessment has become a matter of precision medicine, which is helpful for safe menopausal hormone therapy prescription. With a multidisciplinary approach the current available hormone regimens can be even given to women at intermediate cardiovascular risk, when risk factors such as hypertension and dyslipidemia are adequately monitored and treated.
doi.org/10.1016/j.beem.2021.101576Open accessPubMed 34556415Interventions